RLAY
Common StockRelay Therapeutics, Inc.
Reported Shares
12M
Position Mix
No options reported
Reported Value
$216.6M
Portfolio Weight
16.78%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$1.3B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
RLAY
Common StockRelay Therapeutics, Inc.
Reported Shares
12M
Position Mix
No options reported
Reported Value
$216.6M
Portfolio Weight
16.78%
ELVN
Common StockEnliven Therapeutics, Inc.
Reported Shares
3.3M
Position Mix
No options reported
Reported Value
$150.1M
Portfolio Weight
11.63%
ALKS
Common StockAlkermes plc.
Reported Shares
2.9M
Position Mix
No options reported
Reported Value
$116.5M
Portfolio Weight
9.03%
ANRO
Common StockAlto Neuroscience, Inc.
Reported Shares
2.7M
Position Mix
No options reported
Reported Value
$69.5M
Portfolio Weight
5.39%
SYRE
Common StockSpyre Therapeutics, Inc.
Reported Shares
700K
Position Mix
No options reported
Reported Value
$62.3M
Portfolio Weight
4.83%
AMLX
Common StockAmylyx Pharmaceuticals, Inc.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$58.2M
Portfolio Weight
4.51%
LBRX
Common StockLB PHARMACEUTICALS INC
Reported Shares
1.3M
Position Mix
No options reported
Reported Value
$49.2M
Portfolio Weight
3.81%
DMRA
Common StockDamora Therapeutics, Inc.
Reported Shares
1.9M
Position Mix
No options reported
Reported Value
$41.3M
Portfolio Weight
3.20%
COGT
Common StockCogent Biosciences, Inc.
Reported Shares
1.3M
Position Mix
No options reported
Reported Value
$40.5M
Portfolio Weight
3.14%
TYRA
Common StockTyra Biosciences, Inc.
Reported Shares
1.7M
Position Mix
No options reported
Reported Value
$37.7M
Portfolio Weight
2.92%
CLDX
Common StockCelldex Therapeutics, Inc.
Reported Shares
1M
Position Mix
No options reported
Reported Value
$32.4M
Portfolio Weight
2.51%
PHVS
Common StockPharvaris N.V.
Reported Shares
925K
Position Mix
No options reported
Reported Value
$29.3M
Portfolio Weight
2.27%
SRZN
Common StockSurrozen, Inc./DE
Reported Shares
885K
Position Mix
No options reported
Reported Value
$28.5M
Portfolio Weight
2.21%
KRSA
Common StockKorsana Biosciences, Inc.
Reported Shares
877K
Position Mix
No options reported
Reported Value
$28.1M
Portfolio Weight
2.17%
SGMT
Common StockSagimet Biosciences Inc.
Reported Shares
2.8M
Position Mix
No options reported
Reported Value
$27.2M
Portfolio Weight
2.11%
DFTX
Common StockDefinium Therapeutics, Inc.
Reported Shares
700K
Position Mix
No options reported
Reported Value
$26.6M
Portfolio Weight
2.06%
ADRX
Common StockADARx Pharmaceuticals, Inc.
Reported Shares
1.3M
Position Mix
No options reported
Reported Value
$25.1M
Portfolio Weight
1.95%
EDIT
Common StockEditas Medicine, Inc.
Reported Shares
8.9M
Position Mix
No options reported
Reported Value
$22.8M
Portfolio Weight
1.77%
ENTX
Common StockEntera Bio Ltd.
Reported Shares
7.4M
Position Mix
No options reported
Reported Value
$21.4M
Portfolio Weight
1.66%
ATTO
Common StockAttovia Therapeutics, Inc.
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$19.9M
Portfolio Weight
1.54%